Drugs / Aimmugen™
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00316693 Comparator | Apr 2006 → Feb 2009 | human papilloma virus infection | GlaxoSmithKline | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aimmugen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00316693 ↗ |